Financial support and resources available for businesses impacted by COVID-19.

Support for businesses impacted by COVID-19.

logo of Clementia Pharmaceuticals
Portfolio company

Clementia Pharmaceuticals

Details
Region
Quebec
Industry sector
Drugs
Investment year
2012
Fund
Healthcare Venture Fund
Learn More
About the company

Clementia is a privately-held, clinical stage biotechnology company dedicated to the development and commercialization of treatments for people living with rare diseases. Clementia exploits the use of novel Retinoic acid receptor gamma agonists (RARγ) to address diseases of heterotopic ossification, including Fibrodysplasia Ossificans Progressiva.

Our partnership

Clementia is a BDC Capital Healthcare Venture Fund company, co-managed in partnership by Amplitude Venture Capital.

Contact

Jean-François Pariseau, Founding Partner at Amplitude Venture Capital